Oxymycine LA 300 (Canada)

Manufacturer: Wyeth Animal Health

Sterile Injectable Solution

Din 02274892

Veterinary Use Only

A long acting broad spectrum antibiotic.

Active Ingredient Per Ml

Oxytetracycline dihydrate BP equivalent to 300 mg oxytetracycline base.

Antioxidant: Sodium Formaldehyde Sulphoxylate.

Description

OXYMYCINE LA 300 Injectable Solution is specially formulated to provide sustained antibiotic blood levels up to 4 days in cattle and pigs following a single treatment.

OXYMYCINE LA 300 Injectable Solution is a sterile, long acting stable aqueous solution containing oxytetracycline dihydrate equivalent to 300 mg oxytetracycline base per mL.

Advantages

OXYMYCINE LA 300 Injectable Solution offers the advantage of combining broad spectrum effectiveness against both gram positive and gram negative bacteria, with prolonged antibiotic blood levels up to 4 days duration following a single treatment.

Oxymycine LA 300 Indications

OXYMYCINE LA 300 Injectable Solution is indicated in the treatment of all infections caused by oxytetracycline susceptible bacteria in cattle and pigs.

CATTLE: Bacterial pneumonia, Pasteurellosis (associated with shipping fever complex), Mastitis, Metritis, Calf Scours (bacterial enteritis), Foot Rot, Navel ill, Calf Diphtheria, Leptospirosis, Blackleg/Malignant Edema, Peritonitis, Joint ill.

SWINE: Erysipelas, Bacterial enteritis, Leptospirosis, Metritis, Mastitis, Bacterial pneumonia.

Oxymycine LA 300 Dosage And Administration

For intramuscular or subcutaneous administration to cattle and intramuscular administration to pigs at a single dose rate of 1 mL per 15 kg of live bodyweight (20 mg oxytetracycline per kg bodyweight).

It is recommended that the maximum dose at any one site is 10 mL in cattle and 5 mL in pigs to minimize local tissue irritation at the injection site. Intramuscular injections should be made deep into the fleshy part of the muscle such as the neck. Subcutaneous injections should be administered in the neck region.

Following administration, temporary localized swelling may be observed at the site of injection for several days. This is due to the high concentration and long acting effect of the product.

OXYMYCINE LA 300 Injectable Solution should be warmed to body temperature prior to administration.

If clinical improvement is not observed after 48 hours, clinical re-evaluation may be required. In non-responsive cases, consideration may be given to the use of an alternative antibiotic.

Note

Treatment with OXYMYCINE LA 300 only, in severe disease cases, may be insufficient.

Warnings

Intramuscular administration:

Treated animals must not be slaughtered for use in food for at least 21 days after the latest treatment with this drug. Do not use in lactating dairy cattle.

Subcutaneous administration:

Treated cattle must not be slaughtered for use in food for at least 42 days after the latest treatment with this drug. Do not use in lactating dairy cattle.

Note

To avoid the possibility of excessive trim at the site of injection, do not slaughter cattle for at least 42 days after the latest treatment with this drug.

Oxymycine LA 300 Caution

Occasional hypersensitivity reactions (anaphylaxis) have been observed following the parenteral administration of oxytetracycline. If such side effects occur, discontinue use of the drug and administer epinephrine immediately. The safety of this product in pregnant animals has not been demonstrated.

Storage

Store between 15° and 25°C. Protect from light.

Do not freeze.

Presentation

OXYMYCINE LA 300 Injectable Solution is available in multidose 250 mL and 500 mL vials.

Wyeth Animal Health, Division of Wyeth Canada, Guelph, Ontario N1K 1E4

Net
250 mL	050030L02
500 mL	050030L02

Nac No.

11573570